Technical Analysis for EVGN - Evogene

Grade Last Price % Change Price Change
grade D 1.8 3.51% 0.06
EVGN closed up 3.51 percent on Tuesday, May 21, 2019, on 9 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical EVGN trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish 3.51%
Inside Day Range Contraction 3.51%
Wide Bands Range Expansion 3.51%
Oversold Stochastic Weakness 3.51%
New 52 Week Closing Low Bearish 5.88%
Stochastic Buy Signal Bullish 5.88%
Wide Bands Range Expansion 5.88%
Oversold Stochastic Weakness 5.88%

Older signals for EVGN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.
Biotechnology Genomics Canola Oil Monsanto
Is EVGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.46
52 Week Low 1.67
Average Volume 45,333
200-Day Moving Average 2.4948
50-Day Moving Average 2.0242
20-Day Moving Average 1.927
10-Day Moving Average 1.7939
Average True Range 0.0917
ADX 25.59
+DI 21.0551
-DI 35.7672
Chandelier Exit (Long, 3 ATRs ) 2.0949
Chandelier Exit (Short, 3 ATRs ) 1.9451
Upper Bollinger Band 2.2901
Lower Bollinger Band 1.5639
Percent B (%b) 0.33
BandWidth 37.685522
MACD Line -0.104
MACD Signal Line -0.0909
MACD Histogram -0.0131
Fundamentals Value
Market Cap 46.34 Million
Num Shares 25.7 Million
EPS -0.83
Price-to-Earnings (P/E) Ratio -2.17
Price-to-Sales 23.60
Price-to-Book 1.37
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.89
Resistance 3 (R3) 1.88 1.84 1.88
Resistance 2 (R2) 1.84 1.82 1.85 1.87
Resistance 1 (R1) 1.82 1.80 1.83 1.83 1.86
Pivot Point 1.78 1.78 1.79 1.79 1.78
Support 1 (S1) 1.76 1.76 1.77 1.77 1.74
Support 2 (S2) 1.72 1.74 1.73 1.73
Support 3 (S3) 1.70 1.72 1.73
Support 4 (S4) 1.71